"Hypertension, Portal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Descriptor ID |
D006975
|
| MeSH Number(s) |
C06.552.494
|
| Concept/Terms |
Hypertension, Portal- Hypertension, Portal
- Hypertensions, Portal
- Portal Hypertension
- Portal Hypertensions
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Portal".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Portal".
This graph shows the total number of publications written about "Hypertension, Portal" by people in this website by year, and whether "Hypertension, Portal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 0 | 2 | 2 |
| 1998 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 1 | 4 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 2 | 3 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertension, Portal" by people in Profiles.
-
TIPS Revision: Indications, Techniques, and What to Consider When Revision Fails. Tech Vasc Interv Radiol. 2025 Dec; 28(4):101083.
-
Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Aliment Pharmacol Ther. 2025 Jan; 61(2):346-353.
-
Predictors of long-term clinical outcomes after TIPS: An ALTA group study. Hepatology. 2025 Apr 01; 81(4):1244-1255.
-
Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma. Ann Surg Oncol. 2024 Oct; 31(10):6526-6536.
-
Portosinusoidal Vascular Disorder: A Heretofore Unrecognized Manifestation of Sickle Cell Disease? Mod Pathol. 2024 01; 37(1):100351.
-
Impact of Portal Hypertension on Adverse Events after Splenic Arterial Aneurysm Embolization. J Vasc Interv Radiol. 2022 12; 33(12):1519-1526.e1.
-
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. Gastroenterology. 2020 04; 158(5):1334-1345.e5.
-
Involution of Portal Hypertensive Gastric and Duodenal Polyps Following Liver Transplantation. Clin Gastroenterol Hepatol. 2019 06; 17(7):e77-e78.
-
Challenging cases in rheumatic pregnancies. Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v18-v25.
-
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension. J Viral Hepat. 2017 10; 24(10):823-831.